> Erika Hamilton, MD

Erika Hamilton, MD



Erika P. Hamilton, MD is director of the breast cancer research program and gynecologic cancer research program at the Sarah Cannon Research Institute. She came to SCRI in 2013 as an investigator in drug development with a women’s cancer focus and was named director in 2015. She sees patients who have breast or gynecologic cancers in both the phase I drug development unit and the standard of care clinic including phase II/ III clinical trials. Dr. Hamilton is also a partner within Tennessee Oncology. She is board certified in both internal medicine and oncology.

Dr. Hamilton is chair of the American Society of Clinical Oncology’s Scientific Committee for Metastatic Breast Cancer for 2019-2020 and has served on that committee as a member for the past 3 years. She also serves as an associate editor for Clinical Breast Cancer. She has recently been elected to the board for Susan G. Komen of Central Tennessee and loves interacting with her community.